Cotten Joseph F, Keshavaprasad Bharat, Laster Michael J, Eger Edmond I, Yost C Spencer
Department of Anesthesia and Perioperative Care, University of California San Francisco, USA.
Anesth Analg. 2006 Mar;102(3):779-85. doi: 10.1213/01.ane.0000194289.34345.63.
TWIK-related acid-sensitive K(+)-1 (TASK-1 [KCNK3]) and TASK-3 (KCNK9) are tandem pore (K(2P)) potassium (K) channel subunits expressed in carotid bodies and the brainstem. Acidic pH values and hypoxia inhibit TASK-1 and TASK-3 channel function, and halothane enhances this function. These channels have putative roles in ventilatory regulation and volatile anesthetic mechanisms. Doxapram stimulates ventilation through an effect on carotid bodies, and we hypothesized that stimulation might result from inhibition of TASK-1 or TASK-3 K channel function. To address this, we expressed TASK-1, TASK-3, TASK-1/TASK-3 heterodimeric, and TASK-1/TASK-3 chimeric K channels in Xenopus oocytes and studied the effects of doxapram on their function. Doxapram inhibited TASK-1 (half-maximal effective concentration [EC50], 410 nM), TASK-3 (EC50, 37 microM), and TASK-1/TASK-3 heterodimeric channel function (EC50, 9 microM). Chimera studies suggested that the carboxy terminus of TASK-1 is important for doxapram inhibition. Other K2P channels required significantly larger concentrations for inhibition. To test the role of TASK-1 and TASK-3 in halothane-induced immobility, the minimum alveolar anesthetic concentration for halothane was determined and found unchanged in rats receiving doxapram by IV infusion. Our data indicate that TASK-1 and TASK-3 do not play a role in mediating the immobility produced by halothane, although they are plausible molecular targets for the ventilatory effects of doxapram.
TWIK相关酸敏感钾离子通道-1(TASK-1 [KCNK3])和TASK-3(KCNK9)是串联孔道(K2P)钾离子通道亚基,表达于颈动脉体和脑干。酸性pH值和低氧会抑制TASK-1和TASK-3通道功能,而氟烷可增强该功能。这些通道在通气调节和挥发性麻醉机制中可能发挥作用。多沙普仑通过作用于颈动脉体刺激通气,我们推测这种刺激可能源于对TASK-1或TASK-3钾离子通道功能的抑制。为验证这一点,我们在非洲爪蟾卵母细胞中表达TASK-1、TASK-3、TASK-1/TASK-3异源二聚体和TASK-1/TASK-3嵌合钾离子通道,并研究多沙普仑对其功能的影响。多沙普仑抑制TASK-1(半数最大效应浓度[EC50],410 nM)、TASK-3(EC50,37 μM)和TASK-1/TASK-3异源二聚体通道功能(EC50,9 μM)。嵌合体研究表明,TASK-1的羧基末端对多沙普仑抑制作用很重要。其他K2P通道需要显著更高的浓度才能被抑制。为测试TASK-1和TASK-3在氟烷诱导的不动状态中的作用,我们测定了氟烷的最低肺泡麻醉浓度,发现静脉输注多沙普仑的大鼠中该浓度未发生变化。我们的数据表明,TASK-1和TASK-3在介导氟烷产生的不动状态中不起作用,尽管它们可能是多沙普仑通气效应的分子靶点。